Sharescart Research Club logo
Products
Research
Tools
About
ChatGPT Claude Perplexity
Summarize with
ChatGPT Claude Perplexity
Join Channel
Apollo Green₹ 72 (28.6%)ASK Investment₹ 895 (-3.2%)AVPL ₹ 49 (0%)Bootes Impex₹ 775 (-8.8%)CIAL ₹ 442 (-0.5%)CSK ₹ 254 (-3.1%)ESDS Software₹ 478 (2.8%)Garuda Aerospace₹ 468 (-2.1%)Goodluck Defence₹ 385 (16%)Hero Motors₹ 325 (0%)Hinduja Leyland₹ 248 (0%)ICL Fincorp₹ 25 (0%)Incred Holdings₹ 154 (2.7%)Kineco Limited₹ 3285 (0%)Lava ₹ 60 (15.4%)Market Simplified₹ 26 (-7.1%)Matrix Gas₹ 12 (-20%)Motilal Oswal₹ 12.25 (-2%)MSEI ₹ 6.35 (-2.3%)NCDEX ₹ 368 (-1.6%)NSE ₹ 1985 (-2%)Onix Renewable₹ 68 (21.4%)OYO ₹ 23 (-4.2%)OYO Assets₹ 9.25 (-7%)Philips India₹ 1250 (0%)Polymatech Electronics₹ 56 (-3.4%)SBI Mutual₹ 768 (-0.9%)Taparia Tools₹ 6050 (0%)VCI Chemical₹ 64 (0%)Zepto ₹ 40 (-4.8%)

15 Days Price Change

Shelter Pharma IPO

Closing In

  • days
  • Hours
  • Minutes
  • Seconds

WEBSITE Inc. Year: 2007 Industry: Pharmaceuticals & Drugs Listed Page

Profile
Issue Size --
Profile
Price Range 42  to  42 per share
Profile
Min Investment ₹42
Profile
Lot Size 1
Profile
Face Value ₹10
Profile
Draft Prospectus
Invest Before the IPO Goes Live

Buy unlisted shares early and participate in the growth before public listing.

Profile
  • Basic Info
  • IPO Tentative Timetable
  • IPO Lot Size
  • Subscription Status
  • Financials
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Ratios
  • Growth Rates
  • Other info

Overview

Shelter Pharma Ltd is a dynamic and innovative pharmaceutical company dedicated to advancing global healthcare. With a commitment to research, development, and manufacturing, Shelter Pharma specializes in producing high-quality and affordable medications across a spectrum of therapeutic areas. The company's state-of-the-art facilities and experienced team ensure the production of safe, effective, and accessible pharmaceutical products. Shelter Pharma's mission extends beyond profit, as they actively contribute to improving patient lives by ensuring the availability of essential treatments. Striving for excellence, Shelter Pharma Ltd continues to make significant contributions to the medical field through its unwavering focus on quality, accessibility, and innovation. Read More

Basic Info

Face Value 10 per share

Price 42  to  42 per share

P/E (x) 6.7

Sales( Cr.) 51

PAT( Cr.) 7

EPS 6.3

Draft Prospectus

Exchange BSE-SME

Promoter

Company Promoters

Mr. Mustaqim Nisarahmed Sabugar Mr. Shakil Nisarahmed Sabugar

Pre Issue Share Holding 100%

Post Issue Share Holding 58.86%

Listing Details:

Listing Price: 39.97

Listing Gain: -5.08%

Current Price: 31

Gain On Issue: 31 | 0%

GMP: --

GMP %: -- %

IPO Tentative Timetable

Opening Date Aug 10, 2023
Closing Date Aug 14, 2023
Allotment Aug 15, 2023
Refund Aug 16, 2023
Delivery of Shares Aug 16, 2023
Listing Date Aug 17, 2023

IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 3000 126,000
Retail (Max) 1 3000 126,000
S-HNI (Min) 2 6000 252,000
S-HNI (Max) 7 21000 882,000
B-HNI (Min) 8 24000 1,008,000

Objective of the Issue

1. Working capital requirements 2. General corporate purposes

Issue

Category Nos Bid Bid (x)
QIB 0 0 0x
NII 1908000 12573720 6.6x
Retail 1908000 42510240 22.3x
EMP 0 0 0x
Total 3816000 58194000 15.3x

Net Sales (in cr.)

Total Income (in cr.)

Operating Profit (in cr.)

Net Profit (in cr.)

Shareholder Funds (in cr.)

Total Assets (in cr.)

Shelter Pharma Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 25 28 30 31 28 30 22 30 36 40 51
Other Income 0 0 1 0 0 0 0 0 0 0 0
Total Income 25 28 31 31 28 30 22 30 36 40 51
Total Expenditure 25 28 31 31 28 30 22 27 28 31 41
Operating Profit 0 0 0 0 0 0 0 3 8 9 10
Interest 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 -1 0 0
Profit Before Tax 0 0 0 0 0 0 0 3 7 8 10
Provision for Tax 0 0 0 0 0 0 0 1 2 2 2
Profit After Tax 0 0 0 0 0 0 0 2 5 6 7
Adjustments 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 0 0 0 0 0 0 0 2 5 6 7
Adjusted Earnings Per Share 0 0.1 0.1 0.1 0.1 0.1 0.1 2.4 6.7 5.4 6.3

Shelter Pharma Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 8 8 8 8 8 7 7 9 15 36 43
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 0 0 0 0 0 0 0 0 0 1 1
Other Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0 0
Total Current Liabilities 4 4 4 3 3 3 3 4 6 5 5
Total Liabilities 11 12 12 11 11 11 10 13 21 41 48
Fixed Assets 3 3 3 3 3 2 2 1 2 4 6
Other Non-Current Assets 0 0 0 0 1 1 1 2 1 5 9
Total Current Assets 9 9 9 8 8 8 8 10 19 33 33
Total Assets 11 12 12 11 11 11 10 13 21 41 48

Shelter Pharma Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 0 0 0 0 0 0 0 0 0 0 5
Cash Flow from Operating Activities 0 0 -0 0 0 -0 -0 1 -1 -2 5
Cash Flow from Investing Activities 0 0 -0 -0 0 0 0 -1 0 -5 -7
Cash Flow from Financing Activities 0 0 1 -0 0 0 0 0 1 11 0
Net Cash Inflow / Outflow 0 0 -0 -0 0 0 0 -0 0 5 -2
Closing Cash & Cash Equivalent 0 0 0 0 0 0 0 0 0 5 3

Shelter Pharma Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 0.03 0.06 0.07 0.07 0.08 0.11 0.05 2.37 6.72 5.36 6.26
CEPS(Rs) 0.16 0.2 0.17 0.21 0.25 0.29 0.2 2.59 6.93 5.58 6.49
DPS(Rs) 0 0 0 0 0 0 0 0 0 0.33 0.35
Book NAV/Share(Rs) 8.75 8.74 8.75 8.54 8.63 8.19 7.97 10.31 17.57 30.17 36.14
Core EBITDA Margin(%) 0.37 0.56 -2.3 0.52 0.66 0.81 0.85 9.1 22.31 21.95 19.86
EBIT Margin(%) 0.11 0.21 0.22 0.23 0.31 0.38 0.36 8.6 19.38 21.35 19.37
Pre Tax Margin(%) 0.1 0.19 0.2 0.22 0.29 0.35 0.28 8.34 19.31 20.69 19.1
PAT Margin (%) 0.08 0.17 0.16 0.17 0.22 0.27 0.18 6.11 14.4 15.49 14.29
Cash Profit Margin (%) 0.46 0.52 0.4 0.49 0.64 0.71 0.7 6.67 14.85 16.11 14.82
ROA(%) 0.15 0.41 0.41 0.49 0.55 0.74 0.4 15.94 30.37 19.74 16.14
ROE(%) 0.26 0.74 0.75 0.87 0.96 1.31 0.68 25.95 48.22 25.58 18.88
ROCE(%) 0.28 0.71 0.9 1.16 1.33 1.84 1.29 36.17 59.61 33.62 25.07
Receivable days 39.64 13.9 13.13 10.17 4.32 4.11 11.15 14.36 49.47 77.72 66.01
Inventory Days 68.11 55.25 50.7 44.77 52.22 51.18 67.55 58.83 68.85 81.59 82.22
Payable days 6.06 2.33 2.24 2.01 2.4 2.87 4.93 4.48 5.49 7.45 9.68
PER(x) 0 0 0 0 0 0 0 0 0 9.17 5.78
Price/Book(x) 0 0 0 0 0 0 0 0 0 1.63 1
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0.67 0.97
EV/Net Sales(x) 0.1 0.09 0.02 0.01 0.02 0.02 0.01 0.02 0.25 1.31 0.78
EV/Core EBITDA(x) 19.67 15.26 3.47 2.61 2.41 2.23 0.6 0.19 1.13 5.96 3.92
Net Sales Growth(%) 8.32 12.32 6.62 4.86 -11.86 8.42 -25.22 33.68 20.29 10.71 26.58
EBIT Growth(%) -98.82 111.62 12.01 10.25 14.57 36.69 -30.86 3131.13 171.07 21.97 14.81
PAT Growth(%) -98.78 130.47 0.46 15.02 10.49 33.49 -48.69 4358.74 183.39 19.1 16.73
EPS Growth(%) -98.78 130.47 0.46 15.02 10.49 33.49 -51.87 4358.74 183.39 -20.21 16.73
Debt/Equity(x) 0.33 0.33 0.02 0.01 0.02 0.04 0 0.02 0.13 0.02 0.03
Current Ratio(x) 2.42 2.36 2.29 2.51 2.37 2.33 2.71 2.65 3 6.67 7.19
Quick Ratio(x) 1.27 1.17 1.25 1.28 1.09 1.08 1.33 1.12 1.72 4.68 4.4
Interest Cover(x) 8.44 10.47 10.52 15.14 19.49 12.05 4.62 32.6 278.06 32.42 72.95
Total Debt/Mcap(x) 0 0 0 0 0 0 0 0 0 0.01 0.03

Sihora Industries Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 28% 19% 11% 7%
Operating Profit CAGR 11% 49% 0% 0%
PAT CAGR 17% 52% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -29% NA% NA% NA%
ROE Average 19% 31% 24% 11%
ROCE Average 25% 39% 31% 15%

Company Contact Information

Shelter Pharma Ltd.

Shelter Nagar Opp. Bus Station

IPO Lead Manager(s)

Shelter Pharma Ltd.

Gretex Corporate Services Ltd.

Registrar Info

Shelter Pharma Ltd.

Frequently Asked Questions

All You Need To Know About IPO

When you leave without vesting, generally unvested ESOPs are cancelled. Vested ESOPs usually can be exercised after you depart, often within 3 to 6 months, depending on the company's ESOP plan.

For companies listed on a stock exchange, you can sell the shares any time after you exercise the ESOP option and the shares are in your demat account. If the company is unlisted or otherwise a startup, you can only sell the shares if and when the company announces a buyback or has a process for secondary sales.

Whenever you exercised your options to hold shares, you entered into a market risk situation, and if the valuation of the company drops, so do the shares.

Yes. ESOPs are valuable to the employer in that the employer is able to retain the best talent, align employee interests with company goals, and preserve cash while rewarding performance.

Wealth Icon
Don’t Miss Out on Unlisted Shares

Open your account today and gain instant access to top unlisted shares and pre-IPO opportunities.

whatsapp

Error!